People: Prometic Life Sciences Inc (PLI.TO)
Mr. Charles N. Kenworthy is Non-Independent Director of the Company. Mr. Charles N. Kenworthy is Executive Vice-President, Corporate Strategy, NantWorks, LLC since 2011 and President of Nant Capital, LLC. Mr. Kenworthy received his Bachelor of Arts from the University of California, Los Angeles, in 1980 and his Juris Doctorate from the University of San Diego School of Law in 1985. He joined the law firm of Allen Matkins in the mid-1980's and was a partner when he departed in 2006. Thereafter, he joined Abraxis Biosciences, LLC as Executive Vice-President, Corporate Strategy. Mr. Charles N. Kenworthy was nominated to the Board by California Capital Equity, LLC ("CCE") (an affiliate of Abraxis Bioscience International Holding Company, Inc.), pursuant to a securities purchase agreement (the "Purchase Agreement") entered into between the Corporation and Abraxis Bioscience International Holding Company, Inc. on September 3, 2008. Pursuant to the Purchase Agreement, CCE is entitled to nominate one person for election to the Board.
|Total Annual Compensation, CAD||38,700|
|Restricted Stock Award, CAD||--|
|Long-Term Incentive Plans, CAD||--|
|All Other, CAD||84,409|
|Fiscal Year Total, CAD||123,109|